BlackRock Institutional Trust’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMO
WA
BBA
BFA
FC
DM
BlackRock Institutional Trust's SGMO Position: Q4 2016 in Review
BlackRock Institutional Trust held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q4 2016 at 1,847,789 shares worth $5.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2678.
BlackRock Institutional Trust first reported a position in SGMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $32.8M in Q1 2014. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.
- BlackRock Institutional Trust held 1,847,789 shares of SANGAMO THERAPEUTICS INC worth $5.64M as of Q4 2016.
- BlackRock Institutional Trust left its SANGAMO THERAPEUTICS INC share count unchanged in Q4 2016.
- SANGAMO THERAPEUTICS INC made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2678 holding.
- BlackRock Institutional Trust first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's SANGAMO THERAPEUTICS INC position peaked at $32.8M in Q1 2014.
- 126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.